Transforming drug discovery through the fusion of AI-driven analysis and protein micropatterning

The integration of automated imaging and AI-driven data analysis enables high-throughput, information-rich experimental workflows. Persistent challenges include explainable AI requirements, data quality, and evolving regulatory frameworks supporting non-animal models. These AI-enabled functional micropatterning platforms offer significant benefits for drug discovery. Over the next decade, advances in explainable AI and workflow automation will be essential for widespread adoption, regulatory acceptance, and the realization of closed-loop systems (AI-driven experimental iteration) that reshape pharmaceutical research by enabling close collaboration between scientists and intelligent technologies.